Pfizer chose not to take U.S. taxpayer money to help fund its coronavirus vaccine development, a move that CBS News’ Margaret Brennan pointed out on Sunday is a bit of a financial risk for the pharmaceutical giant.

CEO Albert Bourla admitted that it will indeed “be painful” if the vaccine fails, but “at the end of the day it’s only money” and the lack of taxpayer funds won’t “break our company.”